{"disease":{"id":"cardiomyopathy-familial","name":"cardiomyopathy familial"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05100420","title":"Hypertrophic Cardiomyopathy Registry, Biobank and Imaging Data Repository","phase":"","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":2000,"lead_sponsor_name":"Montreal Heart Institute","has_results":false},{"nct_id":"NCT06546137","title":"National Network for Cardiovascular Genomics: Advancing Cardiovascular Healthcare for Hereditary Diseases in Brazil's Unified Health System Through a Multicenter Registry","phase":"","overall_status":"RECRUITING","enrollment_count":600,"lead_sponsor_name":"Hospital do Coracao","has_results":false},{"nct_id":"NCT05524077","title":"Catheter Ablation Versus Anti-arrhythmic Drugs for Ventricular Tachycardia","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":162,"lead_sponsor_name":"Western Sydney Local Health District","has_results":false},{"nct_id":"NCT03860454","title":"The Deep Phenotype of Lamin A/C Cardiomyopathy","phase":"","overall_status":"UNKNOWN","enrollment_count":150,"lead_sponsor_name":"University College, London","has_results":false},{"nct_id":"NCT04978987","title":"Identification of Disease Specific Pathways and Modifiers in Phospholamban R14del Cardiomyopathy","phase":"","overall_status":"COMPLETED","enrollment_count":103,"lead_sponsor_name":"University Medical Center Groningen","has_results":false},{"nct_id":"NCT02862600","title":"Open-Label Study of Perhexiline in Patients With Hypertrophic Cardiomyopathy and Moderate to Severe Heart Failure","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":35,"lead_sponsor_name":"Heart Metabolics Limited","has_results":true},{"nct_id":"NCT03696628","title":"Modeling and Pharmacological Targeting of Genetic Cardiomyopathy in Children Via Cardiomyocytes Derived From Induced Pluripotent Stem Cells (DMDstem)","phase":"NA","overall_status":"COMPLETED","enrollment_count":24,"lead_sponsor_name":"University Hospital, Montpellier","has_results":false},{"nct_id":"NCT01604122","title":"Burden of Disease Study In Patients With Transthyretin Familial Amyloidosis Polyneuropathy (TTR-FAP) orTransthyretin Cardiomyopathy (TTR-CM) And Caregivers","phase":"","overall_status":"COMPLETED","enrollment_count":1,"lead_sponsor_name":"Pfizer","has_results":true}],"total":8},"guidelines":[],"source":"Drug Landscape verified database"}